Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH3 | Q9ULD8 | 13/20 | 0.90 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 1/20 | 0.62 |
| ▸ | CA9 | Q16790 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12732294 | 1.00 | KCNH3 (0.90) | KCNH3RECQLMCL1CA1CA2 | |
| SCHEMBL12445538 | 0.87 | KCNH3 (0.83) | KCNH3RECQLMCL1CA1CA2 | |
| SCHEMBL16361226 | 0.85 | KCNH3 (0.81) | KCNH3RECQLMCL1CA1CA2 | |
| SCHEMBL27344687 | 0.84 | KCNH3 (0.79) | KCNH3RECQLMCL1 | |
| SCHEMBL29561075 | 0.83 | KCNH3 (0.64) | KCNH3RECQLMCL1CA1CA2 | |
| SCHEMBL15094204 | 0.83 | KCNH3 (0.64) | KCNH3CA1CA2CA9 | |
| SCHEMBL15094945 | 0.83 | KCNH3 (0.64) | KCNH3RECQLMCL1CA1CA2 | |
| SCHEMBL13581628 | 0.83 | KCNH3 (0.64) | KCNH3RECQLMCL1CA1CA2 | |
| SCHEMBL3300123 | 0.83 | KCNH3 (0.97) | KCNH3RECQLMCL1 | |
| SCHEMBL6235017 | 0.82 | NR1I2 (0.78) | KCNH3RECQLMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8198387-B2 | Proton-conducting compound and proton-conducting polymer | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-06-12 | — | — | US | disclosed |
| US-8198387-B2 | Proton-conducting compound and proton-conducting polymer | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-06-12 | — | — | US | disclosed |
| US-20100063249-A1 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER | NIPPON STREEL CHEMICAL CO., LTD (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100063249-A1 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER | NIPPON STREEL CHEMICAL CO., LTD (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2078715-A1 | PROTON CONDUCTING COMPOUND AND PROTON CONDUCTING POLYMER | Nippon Steel Chemical Co., Ltd. (JP) | 2009-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063249-A1 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER | HRH3, H1-3, H1-4 | KCNH3 49/4885RECQL 763/4885MCL1 2141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.